tiprankstipranks

Analyst Profile

Followed by 886 followers
.
Andrew Fein

Andrew Fein

H.C. Wainwright
Wall Street Analyst
#7,797 out of 7,963 Wall Street Analysts
#21,703 out of 22,261 experts

Success Rate

31%
137 out of 446 transactions made a profit

Average Return

-14.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Andrew Fein's trades since 2010 and holding each position for 1 Year would result in 30.72% of your transactions generating a profit, with an average return of -14.2% per rating.

Stock Rating Distribution

2KRatings
91.93% Buy
8.07% Hold
0.00% Sell
Distribution of Andrew Fein's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Bellus Health Inc.
(BLU)
Rating:Buy
Date:Aug 12, 2021 - Aug 12, 2022
Return:+247.00%
The most profitable rating made by Andrew Fein

Andrew Fein's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
AVNR
Avanir Pharmaceuticals
Nov 01, 2010
Buy
Reiterated
2Ratings
0.00%
Altimmune
Aug 11, 2014
Buy
Reiterated
$4.00
(-68.30% Downside)
2Ratings
0.00%
Neptune Wellness Solutions
Oct 03, 2014
Buy
Reiterated
$9.00
(504.03% Upside)
2Ratings
0.00%
Lisata Therapeutics
Nov 19, 2014
Buy
Reiterated
$20.00
(352.49% Upside)
1Ratings
0.00%
Molecular Templates
Dec 08, 2014
Buy
Reiterated
$12.00
(1561.82% Upside)
4Ratings
0.00%
TTHI
Transition Therapeutics
Feb 10, 2015
Buy
Reiterated
2Ratings
0.00%
Abeona Therapeutics
May 18, 2015
Buy
Initiated
$15.00
(406.76% Upside)
1Ratings
0.00%
Synthetic Biologics
Jun 04, 2015
Buy
Reiterated
$4.00
(277.36% Upside)
3Ratings
0.00%
CLPM
Celator Pharmaceuticals
May 11, 2016
Buy
Reiterated
2Ratings
0.00%
Invivo Therapeutics Holdings
Jul 29, 2016
Buy
Reiterated
$25.00
(488.24% Upside)
6Ratings
0.00%
List of latest recommendations made by Andrew Fein. Click to expand and see Andrew Fein's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >